Volume | 752,696 |
|
|||||
News | - | ||||||
Day High | 0.78949 | Low High |
|||||
Day Low | 0.7327 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Gritstone bio Inc | GRTS | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
0.77 | 0.7327 | 0.78949 | 0.782 | 0.796 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
3,578 | 752,696 | $ 0.7625131 | $ 573,941 | - | 0.6716 - 3.33 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
18:37:42 | formt | 200 | $ 0.7773 | USD |
Gritstone bio Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
76.49M | 98.07M | - | 16.34M | -138.49M | -1.41 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Gritstone bio News
Loading Messages....
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical GRTS Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.77 | 0.83 | 0.7101 | 0.7749241 | 691,871 | 0.0073 | 0.95% |
1 Month | 0.7769 | 0.855 | 0.701 | 0.7823863 | 1,548,534 | 0.0004 | 0.05% |
3 Months | 2.84 | 2.94 | 0.6716 | 1.06 | 2,906,024 | -2.06 | -72.63% |
6 Months | 1.77 | 3.17 | 0.6716 | 1.68 | 2,501,568 | -0.9927 | -56.08% |
1 Year | 2.36 | 3.33 | 0.6716 | 1.80 | 2,052,095 | -1.58 | -67.06% |
3 Years | 10.45 | 14.42 | 0.6716 | 3.80 | 1,413,886 | -9.67 | -92.56% |
5 Years | 9.94 | 34.67 | 0.6716 | 6.46 | 1,128,241 | -9.16 | -92.18% |
Gritstone bio Description
Gritstone Bio Inc is a biotechnology company. The company is engaged in developing personalized cancer immunotherapies to fight multiple cancer types and infectious diseases. It is building a pipeline of Immunotherapies product candidates for patients with solid tumors, which includes GRANITE, SLATE, BiSAb, among others. |